Sugarlo Tablets

Active Ingredient: 50 mg of vildagliptin
Indication: Vildagliptin is indicated in the treatment of type 2 diabetes mellitus in
adults:
As monotherapy, dual oral therapy in combination with metformin, sulphonylurea,
and thiazolidinedione and triple oral therapy in combination with sulphonylurea and
metformin.
Vildagliptin is also indicated for use in combination with insulin (with or without
metformin)

Description

Active Ingredient: 50 mg of vildagliptin
Indication: Vildagliptin is indicated in the treatment of type 2 diabetes mellitus in
adults:
As monotherapy, dual oral therapy in combination with metformin, sulphonylurea,
and thiazolidinedione and triple oral therapy in combination with sulphonylurea and
metformin.
Vildagliptin is also indicated for use in combination with insulin (with or without
metformin)